Cymed Ostomy
Private Company
Funding information not available
Overview
Cymed Ostomy, founded in 2003 and headquartered in Portland, USA, is a private commercial-stage company in the medical device sector. It has developed and commercialized a proprietary adhesive technology, MicroSkin®, which forms the core of its ostomy pouching systems designed for enhanced patient comfort and lifestyle flexibility. The company operates a direct-to-consumer e-commerce model, offers Medicare reimbursement, and targets the global ostomy care market. Its value proposition centers on a durable, waterproof, and breathable barrier that supports an active lifestyle.
Technology Platform
MicroSkin®, a proprietary transparent, hypoallergenic, latex-free polyurethane polymer film that is thin (1/1000 inch), highly elastic (500% stretch), waterproof, breathable, and durable. It serves as the adhesive barrier for all ostomy pouching systems.
Opportunities
Risk Factors
Competitive Landscape
Cymed competes in the ostomy care market against dominant multinational players like Coloplast, ConvaTec, and Hollister. Its competitive advantage is its proprietary MicroSkin® adhesive, which offers superior comfort and durability for active users. However, it lacks the broad product portfolios and deep clinical relationships of its larger rivals.